Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Apr;45(8):1168.
doi: 10.1111/apt.13998.

Editorial: co-existing immune-mediated disease in inflammatory bowel diseases - a new disease severity indicator? Author's reply

A N Ananthakrishnan  1
Affiliations
Editorial

Editorial: co-existing immune-mediated disease in inflammatory bowel diseases - a new disease severity indicator? Author's reply

A N Ananthakrishnan. Aliment Pharmacol Ther. 2017 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Ananthakrishnan has served on scientific advisory boards for Abbvie, Takeda, and Merck.

The authors’ declarations of personal and financial interests are unchanged from those in the original article.

Comment on

References

    1. Vegh Z, Bessissow T, Afif W, Lakatos PL. Editorial: co-existing immune-mediated disease in inflammatory bowel diseases -a new disease severity indicator? Aliment Pharmacol Ther. 2017 in press. - PubMed
    1. Vavricka SR, Schoepfer A, Scharl M, Lakatos PL, Navarini A, Rogler G. Extraintestinal Manifestations of Inflammatory Bowel Disease. Inflamm Bowel Dis. 2015;21(8):1982–1992. - PMC - PubMed
    1. Conway G, Velonias G, Andrews E, Garber JJ, Yajnik V, Ananthakrishnan AN. The impact of co- existing immune-mediated on phenotype and outcomes in inflammatory bowel diseases. Aliment Pharmacol Ther. 2017 doi: 10.1111/apt.13940. - DOI - PMC - PubMed

LinkOut - more resources